Stocks Comparison
Boston Scientific vs Solventum: revenue, profit, margins and growth compared
Boston Scientific brought in $20.1B of revenue in fiscal 2025, Solventum $8.3B in fiscal 2025. Revenue changed by +19.9% at Boston Scientific and +0.9% at Solventum on the year before, so Boston Scientific grew faster. Boston Scientific kept 14.4% of its revenue as net profit, Solventum 18.7%. Free cash flow was $3.7B at Boston Scientific and -$10M at Solventum.
Side by side, latest fiscal year
| BSX | SOLV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $20.1B | $8.3B |
| Revenue growth | +19.9% | +0.9% |
| Net income | $2.9B | $1.6B |
| Net margin | 14.4% | 18.7% |
| Free cash flow | $3.7B | -$10M |
| Free cash flow margin | 18.2% | -0.1% |
| Earnings per share (diluted) | $1.94 | $8.88 |
| Cash | $2B | $878M |
| Debt | $11.1B | $5B |
| Price to earnings | 22.6 | 10.1 |
| Market value | $63.7B | $15.2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #30 of 523 · Health care | #49 of 523 · Health care |
Over the years
Questions about Boston Scientific and Solventum
Which is bigger by revenue, Boston Scientific or Solventum?
Boston Scientific is bigger by revenue: $20.1B in fiscal 2025, against $8.3B for Solventum in fiscal 2025.
Which keeps more of its revenue as profit, Boston Scientific or Solventum?
Boston Scientific had a net margin of 14.4% in fiscal 2025; Solventum had 18.7% in fiscal 2025.
Which grew revenue faster, Boston Scientific or Solventum?
In their latest fiscal years revenue changed by +19.9% at Boston Scientific and +0.9% at Solventum.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.